Go Mediaction

Main Menu

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis

Go Mediaction

Header Banner

Go Mediaction

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis
Medical diagnosis
Home›Medical diagnosis›Metaverse Leader ImmersiveTouch Obtains FDA Clearance for New Suite of Medical Diagnostic and Treatment Planning Tools

Metaverse Leader ImmersiveTouch Obtains FDA Clearance for New Suite of Medical Diagnostic and Treatment Planning Tools

By Deborah A. Gray
November 30, 2021
0
0

CHICAGO–(BUSINESS WIRE)–ImmersiveTouch, a leading medical technology company developing the digital surgery metaverse, today announced, in conjunction with RSNA 2021, that it has received 510(k) clearance from the Food and Drug Administration ( FDA) for its modular software package that allows users to import, view, and automatically segment medical images to create accurate three-dimensional representations. Giving surgeons the ability to diagnose and treat patients virtually will reduce scheduling hours and increase efficiency, which is crucial for doctors and patients.

Segmented 3D models can be used for medical diagnosis, anatomical measurement, treatment planning, and generation of output files for additive manufacturing. ImmersiveTouch is the first patient-specific automatic segmentation technology for generating virtual reality surgical plans that has been used in more than 900 procedures this year and is currently deployed in nearly 70 leading hospitals.

Dr. Matthew Ranzer, Doctor of Plastic Surgery at Mount Sinai Hospital, says, “One of the things I like about ImmersiveTouch is that it’s not expensive, but it adds value to our system. The ability to simulate these surgical procedures in great detail makes our operations more efficient and safer for our patients and provides a real benefit to our hospital and our community.

The healthcare metaverse is booming. According to a study published by Facts and Factors, the virtual reality in healthcare market size is expected to grow at a CAGR of 34.89% to reach $40.98 billion by 2026, from 2.70 billion dollars in 2020.

“As the healthcare industry really begins to embrace technological advancements, we are able to help reduce surgical planning and operating times, improving surgical efficiency and minimizing workflow disruptions” , says Pat Banerjee, CEO of ImmersiveTouch.

ImmersiveTouch COO Jay Banerjee says, “Adding this additional FDA 510(k) clearance for medical diagnosis and treatment planning to our portfolio just reinforces what ImmersiveTouch can offer surgeons. .

About ImmersiveTouch, Inc.

ImmersiveTouch offers clinicians greater accuracy and consistency of care by using technology to simulate each patient’s unique pathology in 3D through its immersive VR metaverse. The company’s proprietary platform integrates solutions for surgical planning, education and patient engagement. www.immersivetouch.com/

Tagsmarket size

Categories

  • Drug discovery
  • Medical diagnosis
  • Medical field
  • Prescription drugs

Recent Posts

  • Drug Discovery Informatics Market growth opportunities to be exploited
  • key vendors, trends, analysis, segmentation, forecast to 2029 – Designer Women
  • Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com
  • PROBE AND ACT ON PRESCRIPTION DRUGS ABUSE
  • Prescription Drug Consumption Market Size, Share and Forecast to 2028 | Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD) – Designer Women

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • November 2020
  • September 2020
  • May 2020
  • March 2020
  • September 2019
  • May 2019
  • August 2018
  • December 2013
  • Privacy Policy
  • Terms and Conditions